Kessler ER - Search Results

1

Racial differences in survival for early stage (T1) penile cancer: Analysis from the SEER database.

Candelario NC, Molina E, Bourlon MT, Kim SP, Kessler ER, Spiess PE, Flaig TW. Candelario NC, et al. Among authors: kessler er. Urol Oncol. 2023 Aug;41(8):359.e15-359.e23. doi: 10.1016/j.urolonc.2023.05.018. Epub 2023 Jun 20. Urol Oncol. 2023. PMID: 37344326 Free PMC article.

2

Axitinib, a new therapeutic option in renal cell carcinoma.

Kessler ER, Bowles DW, Flaig TW, Lam ET, Jimeno A. Kessler ER, et al. Drugs Today (Barc). 2012 Oct;48(10):633-44. doi: 10.1358/dot.2012.48.10.1860768. Drugs Today (Barc). 2012. PMID: 23110259 Review.

3

Optimal management of recurrent prostate cancer in older patients.

Kessler ER, Flaig TW. Kessler ER, et al. Drugs Aging. 2012 Nov;29(11):871-83. doi: 10.1007/s40266-012-0021-4. Drugs Aging. 2012. PMID: 23135826 Review.

4

Targeted therapy in advanced urothelial carcinoma.

Verdoorn BP, Kessler ER, Flaig TW. Verdoorn BP, et al. Among authors: kessler er. Oncology (Williston Park). 2013 Mar;27(3):219-26. Oncology (Williston Park). 2013. PMID: 23687793 Free article. Review.

5

Collision renal cell papillary and medullary carcinoma in a 66-year-old man.

Lam ET, Kessler ER, Flaig TW, La Rosa FG. Lam ET, et al. Among authors: kessler er. Oncology (Williston Park). 2013 Sep;27(9):893, 896, 898. Oncology (Williston Park). 2013. PMID: 24282987 Free article. No abstract available.

6

Sequencing medical therapy in prostate cancer: not as easy as 1-2-3.

Kessler ER, Flaig TW. Kessler ER, et al. Oncology (Williston Park). 2013 Nov;27(11):1158-60. Oncology (Williston Park). 2013. PMID: 24575544 Free article. No abstract available.

7

Geriatric considerations in the treatment of advanced prostate cancer.

Kessler ER, Flaig TW. Kessler ER, et al. F1000Prime Rep. 2014 May 6;6:33. doi: 10.12703/P6-33. eCollection 2014. F1000Prime Rep. 2014. PMID: 24860655 Free PMC article. Review.

8

Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?

Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Amini A, et al. Among authors: kessler er. Pract Radiat Oncol. 2015 Nov-Dec;5(6):e589-e596. doi: 10.1016/j.prro.2015.05.004. Epub 2015 Jun 30. Pract Radiat Oncol. 2015. PMID: 26142027 Free PMC article.

9

Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.

Amini A, Raben D, Crawford ED, Flaig TW, Kessler ER, Lam ET, Maroni P, Pugh TJ. Amini A, et al. Among authors: kessler er. Urol Oncol. 2017 Jun;35(6):438-446. doi: 10.1016/j.urolonc.2017.01.013. Epub 2017 Feb 15. Urol Oncol. 2017. PMID: 28214281

10

Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.

Kessler ER, Gao D, Flaig TW, Breaker K, Wold M, Wacker M, Lam ET. Kessler ER, et al. Ann Oncol. 2017 Mar 1;28(3):668. doi: 10.1093/annonc/mdw674. Ann Oncol. 2017. PMID: 28426121 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters